The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer-Reference-Cited by-同舟云学术

The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer

Published:2019-11 Issue: Volume:98 Page:48-52
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

De Marchi Pedro,Melendez Matias E.,Laus Ana C.,Kuhlmann Pamela A.,de Carvalho Ana Carolina,Arantes Lidia Maria R.B.,Evangelista Adriane F.,Andrade Edilene S.,de Castro Gilberto,Reis Rui M.,Carvalho André Lopes,de Souza Viana Luciano

Funder

CNPq

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference39 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group;Lefebvre;J Natl Cancer Inst,1996

3. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach;Posner;Semin Oncol,2004

4. Head and neck cancer;Forastiere;N Engl J Med,2001

5. Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Head and Neck Cancer. Version I; 2016. [Internet] 2016 [cited 24/08/2016]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer;Clinical and Translational Science;2024-05

2. Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers;Frontiers in Oncology;2022-07-06

3. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients;Biochemical Genetics;2022-02-19

4. Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas;Clinical Cancer Research;2021-03-30

5. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma;Molecular Biology Reports;2021-01-03